The UFC has suspended Jaqueline Amorim for six months following a drug test that flagged for ostarine. An investigation pointed to a contaminated supplement as the source of the positive result.
The UFC has suspended Jaqueline Amorim for six months after a drug test flagged the banned substance ostarine. An investigation traced the positive result to a contaminated supplement, which was cited as the source of the violation.
Ostarine is a selective androgen receptor modulator that appears on the list of prohibited substances in anti-doping programs. The finding of a tainted supplement as the origin points to an unintentional ingestion, though the six-month suspension still stands.
Amorim, a 31-year-old Brazilian who trains out of American Top Team, carries a professional record of 10-2-0. She fights from an orthodox stance and stands five-foot-three, or 160 cm, with a 68-inch reach of 173 cm.
Her statistical profile shows a fighter who leans on her grappling. She averages 2.16 takedowns per 15 minutes and attempts 3.8 submissions over the same span, a notably high submission rate that reflects her hunt for finishes on the mat. On the feet, she lands 2.43 significant strikes per minute and connects at 50 percent accuracy.
Why it matters
- The six-month suspension sidelines Amorim for half a year, interrupting her momentum and limiting her chances to build on a 10-2-0 record.
- The contaminated-supplement finding underscores the risk fighters face from unregulated products, even when no deliberate use is found.
- For a grappling-heavy fighter with a high submission-attempt rate, the layoff delays her return to a style that has defined her work in the cage.
The suspension will keep Amorim out of competition for the duration of the six-month period.
